RecruitingPhase 3NCT06498635Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialSponsor: National Cancer Institute (NCI)Cary, NC · Durham, NC · +278 more sites
RecruitingPhase 3NCT06216301LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCSponsor: NovoCure GmbHCary, NC · +37 more sites
RecruitingPhase 2NCT05642572Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkCary, NC · Durham, NC · Garner, NC · +451 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAsheboro, NC · +1226 more sites